$2.9 Billion is the total value of Weiss Multi-Strategy Advisers LLC's 395 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FXI | ISHARES FTSE/XINHUA CHINA 25call | $395,190,000 | +8.7% | 9,495,200 | 0.0% | 13.61% | +53.3% | |
| EEM | ISHARES MSCI EMERGING MKTcall | $252,961,000 | -5.5% | 6,438,300 | 0.0% | 8.71% | +33.3% | |
| AIG | AMERICAN INTERNATIONAL GROUP | $25,205,000 | +3.7% | 450,000 | 0.0% | 0.87% | +46.1% | |
| HIG | ITT HARTFORD | $10,423,000 | +11.9% | 250,000 | 0.0% | 0.36% | +58.1% | |
| SHPG | SHIRE PLC-ADR | $8,502,000 | -18.0% | 40,000 | 0.0% | 0.29% | +15.8% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $6,206,000 | -22.5% | 141,432 | 0.0% | 0.21% | +9.2% | |
| ALKS | ALKERMES INC. | $6,149,000 | +36.6% | 105,000 | 0.0% | 0.21% | +92.7% | |
| PLL | PALL CORP | $4,757,000 | +20.9% | 47,000 | 0.0% | 0.16% | +70.8% | |
| Q | QUINTILES TRANSNATIONAL HOLD | $3,827,000 | +5.5% | 65,000 | 0.0% | 0.13% | +48.3% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $3,493,000 | +28.2% | 110,000 | 0.0% | 0.12% | +79.1% | |
| VMW | VMWARE INC-CLASS A | $3,301,000 | -12.1% | 40,000 | 0.0% | 0.11% | +23.9% | |
| WBMD | WEBMD HEALTH CORP-CLASS A | $3,243,000 | -5.4% | 82,000 | 0.0% | 0.11% | +33.3% | |
| LEA | LEAR CORP | $2,942,000 | +13.5% | 30,000 | 0.0% | 0.10% | +60.3% | |
| SYK | STRYKER CORP | $2,830,000 | +16.8% | 30,000 | 0.0% | 0.10% | +64.4% | |
| ARES | ARES MANAGEMENT LP | $2,571,000 | -2.1% | 150,000 | 0.0% | 0.09% | +39.1% | |
| ELGX | ENDOLOGIX STK | $2,294,000 | +44.3% | 150,000 | 0.0% | 0.08% | +102.6% | |
| ESXB | COMMUNITY BANKERS TRUST CORP | $2,265,000 | +1.1% | 512,500 | 0.0% | 0.08% | +41.8% | |
| CEQP | CRESTWOOD EQUITY PARTNERS LPcall | $2,025,000 | -23.4% | 250,000 | 0.0% | 0.07% | +7.7% | |
| CNA | CNA FINANCE CORP | $1,936,000 | +1.8% | 50,000 | 0.0% | 0.07% | +45.7% | |
| NVS | NOVARTIS ADR | $1,946,000 | -1.6% | 21,000 | 0.0% | 0.07% | +39.6% | |
| MDT | MEDTRONIC PLC | $1,805,000 | +16.5% | 25,000 | 0.0% | 0.06% | +63.2% | |
| GNTX | GENTEX CORP | $1,626,000 | +34.9% | 45,000 | 0.0% | 0.06% | +93.1% | |
| XLV | HEALTH CARE SELECT SECTORput | $1,368,000 | +7.0% | 20,000 | 0.0% | 0.05% | +51.6% | |
| PRTA | PROTHENA CORPORATION PLC | $1,349,000 | -6.3% | 65,000 | 0.0% | 0.05% | +31.4% | |
| OCRX | OCERA THERAPEUTICS INC | $1,338,000 | +30.0% | 210,000 | 0.0% | 0.05% | +84.0% | |
| AFFX | AFFYMETRIX | $987,000 | +23.7% | 100,000 | 0.0% | 0.03% | +78.9% | |
| ALXN | ALEXION PHARMACEUTIC | $925,000 | +11.6% | 5,000 | 0.0% | 0.03% | +60.0% | |
| MZOR | MAZOR ROBOTICS LTD-SPON ADR | $869,000 | +5.3% | 70,000 | 0.0% | 0.03% | +50.0% | |
| PACB | PACIFIC BIOSCIENCES OF CALIF | $841,000 | +59.6% | 107,300 | 0.0% | 0.03% | +123.1% | |
| CNAT | CONATUS PHARMACEUTICALS INC | $735,000 | +14.3% | 105,000 | 0.0% | 0.02% | +56.2% | |
| AKRXQ | AKORN INC | $724,000 | -0.1% | 20,000 | 0.0% | 0.02% | +38.9% | |
| QGEN | QIAGEN N.V. | $704,000 | +3.1% | 30,000 | 0.0% | 0.02% | +41.2% | |
| VCYT | VERACYTE INC | $676,000 | -1.0% | 70,000 | 0.0% | 0.02% | +35.3% | |
| XOMA | XOMA LTD ORD | $646,000 | -14.8% | 180,000 | 0.0% | 0.02% | +15.8% | |
| CRIS | CURIS STK | $368,000 | +6.7% | 245,000 | 0.0% | 0.01% | +62.5% | |
| KBIO | KALOBIOS PHARMACEUTIALCS | $346,000 | +11.6% | 200,000 | 0.0% | 0.01% | +50.0% | |
| ANTH | ANTHERA PHARMACEUTICALS INC | $332,000 | -17.6% | 210,000 | 0.0% | 0.01% | +10.0% | |
| BIOS | BIOSCRIP INC | $280,000 | +1.4% | 40,000 | 0.0% | 0.01% | +42.9% | |
| MDR | MCDERMOTT INTERNATIONALcall | $291,000 | -49.1% | 100,000 | 0.0% | 0.01% | -28.6% | |
| MEIP | MEI PHARMA INC | $278,000 | -38.1% | 65,000 | 0.0% | 0.01% | -9.1% | |
| VXX | IPATH S&P VIX S/T ETN | $236,000 | +0.9% | 7,495 | 0.0% | 0.01% | +33.3% | |
| LPTN | LPATH INC CLASS A | $212,000 | -19.7% | 75,000 | 0.0% | 0.01% | +16.7% | |
| RPTP | RAPTOR PHARMACEUTICALS CORPcall | $210,000 | +9.4% | 20,000 | 0.0% | 0.01% | +40.0% | |
| VVUS | VIVUS INC | $144,000 | -25.4% | 50,000 | 0.0% | 0.01% | 0.0% | |
| AKAOQ | ACHAOGEN INC | $131,000 | +45.6% | 10,000 | 0.0% | 0.01% | +150.0% | |
| TRGT | TARGACEPT INC | $145,000 | +4.3% | 55,000 | 0.0% | 0.01% | +66.7% | |
| NVAX | NOVAVAX STK | $119,000 | +43.4% | 20,000 | 0.0% | 0.00% | +100.0% | |
| NSPR | INSPIREMD INC | $19,000 | -65.5% | 25,000 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 42 | Q3 2023 | 0.4% |
| EDWARDS LIFESCIENCE CORPORAT | 42 | Q3 2023 | 0.3% |
| MERCK & CO | 42 | Q3 2023 | 0.4% |
| BIOMARIN PHARMACEUTICAL | 42 | Q3 2023 | 0.4% |
| VERTEX PHARMACEUTICA | 41 | Q3 2023 | 0.5% |
| RIGEL PHARMACEUTICALS INC | 41 | Q3 2023 | 0.1% |
| BOSTON SCIENTIFIC | 40 | Q3 2023 | 0.4% |
| PACIFIC BIOSCIENCES OF CALIF | 40 | Q3 2023 | 0.5% |
| ASTRAZENECA PLC-SPONS ADR | 39 | Q3 2023 | 0.3% |
| ABIOMED INC | 38 | Q3 2022 | 0.3% |
View Weiss Multi-Strategy Advisers LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| COMSCORE, INC. | February 14, 2023 | 9,022,812 | 9.8% |
| NETSTREIT Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| RPT RealtySold out | February 14, 2022 | 0 | 0.0% |
| Tiberius Acquisition Corp | February 12, 2019 | 1,327,700 | 6.2% |
| Ashford Hospitality Prime, Inc. | February 14, 2017 | 1,183,378 | 4.6% |
| Community Bankers Trust Corp | February 12, 2014 | 500,000 | 2.3% |
| Crumbs Bake Shop, Inc.Sold out | February 12, 2013 | 0 | 0.0% |
| WESTERN LIBERTY BANCORP | February 13, 2012 | 1,165,817 | 8.1% |
| 57th Street General Acquisition Corp | February 11, 2011 | 350,000 | 5.8% |
| CENTERLINE HOLDING CO | February 11, 2011 | 2,759,200 | 0.8% |
View Weiss Multi-Strategy Advisers LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-12 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Weiss Multi-Strategy Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.